Skip Navigation LinksHome | Editors' Blog
By this time next week, we should know the answer to a question that has been on the minds of health care stakeholders since July:
What in the world will CMS do with E/M visits?

After years of resistance, CMS is working on a plan to negotiate Part B drug prices, predicting large savings for its programs and patients as a result. The plan would also increase provider reimbursement on those drugs to make up for sequestration cuts.

We talked to an occupational therapist and practice expert about how to succeed at patient and provider outreach in the therapy world.
It may sound counterintuitive, but two patients who are attributed the same diagnosis during a patient encounter can have wildly divergent risk-adjustment coding scores.
When coding under a risk-adjustment paradigm, capturing the full range of a patient’s chronic conditions takes on elevated importance. That’s because your payments, and ultimately your coding compliance, may be impacted.


User Name:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top